Many of the major advances in oncology over the past 2 decades are attributable to precision medicine, defined as biomarker-driven treatment. Whether the results of precision medicine are real or an illusion is discussed here.
No takes yet. Share an insight, caveat, or question.
Subbiah et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: